Gain Therapeutics develops small molecule drugs for neurological and rare genetic diseases, based in Bethesda, Maryland. It last closed at $1.00 on Nov 20, down 4.82% on the day. The next earnings report for GANX is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, GANX reported EPS of -$0.07. Over its last 8 reports the stock moved an average of 3.0% the session after earnings.
AI Auto Pilots
Is GANX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GANX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GANXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GANX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 10% below its 20 day and 40% below its 50 day average. It is 80% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 39). The nearest support is the Pivot S1 at $0.95, and the nearest resistance the Pivot at $1.02.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 12.7%/day
Key levels
$4.3452 week high+334.0%
$1.80200 day average+80.0%
$1.61100 day average+61.0%
$1.4050 day average+40.0%
$1.18Swing high (Nov 10)+18.0%
$1.0920 day average+9.0%
$1.08Pivot R1+8.0%
$1.02Pivot+2.0%
$1.00Last close
$0.95Pivot S1−5.0%
$0.9452 week low−6.0%
$0.94Swing low (Nov 5)−6.0%
Indicators
RSI (14)
39.03
Weak, oversold below 30
Neutral
MACD
-0.09
Above its signal line
Bullish
Stochastic
31.4
Middle of its range
Neutral
ADX (14)
26.9
Trending down
Williams %R
-83.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−3.0%
Change over 10 sessions
Bearish
ATR (14)
$0.13
Typical daily range, 12.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 27.4%/day
Key levels
$4.3452 week high+334.0%
$1.80200 day average+80.0%
$1.61100 day average+61.0%
$1.4050 day average+40.0%
$1.18Swing high (Nov 10)+18.0%
$1.0920 day average+9.0%
$1.08Pivot R1+8.0%
$1.02Pivot+2.0%
$1.00Last close
$0.95Pivot S1−5.0%
$0.9452 week low−6.0%
$0.94Swing low (Nov 5)−6.0%
Indicators
RSI (14)
30.87
Weak, oversold below 30
Neutral
MACD
-0.23
Below its signal line
Bearish
Stochastic
6.0
Near the bottom of its range
Oversold
ADX (14)
14.2
No clear trend
Williams %R
-95.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-133.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−42.9%
Change over 10 sessions
Bearish
ATR (14)
$0.27
Typical daily range, 27.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GANX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GANX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GANX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GANXHow many large options trades hit GANX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GANX in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GANX is in one of them and how their past GANX trades turned out.
Gain Therapeutics is a biotechnology company in Bethesda, Maryland, that develops small molecule drugs for diseases caused by misfolded proteins. Its lead candidate, GT-02287, is being tested for Parkinson's disease. The company is also working on treatments for lysosomal storage disorders, metabolic disorders and oncology. It uses its Magellan computational platform to find sites on disease-linked proteins where drugs can bind and to design molecules that fit those sites.